Erin B Lally, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lally’s office at (408) 495-8800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A143148 · Current
Licensed to practise in California · since 2016 · expires 2028-06-30 · Sidney Kimmel Medical College at Thomas Jefferson University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$288,942
Medicare paid this office $288,942 for 358 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, aflibercept, 1 mg | 14 | $94,545 | None |
| Established patient complete exam of visual system | 273 | $61,737 | $110 |
| Removal of cataract with insertion of prosthetic lens | 36 | $27,089 | $521 |
| New patient complete exam of visual system | 120 | $14,918 | $124 |
| Imaging of retina | 224 | $14,832 | $36 |
See all 15 services
| Injection, aflibercept, 1 mg | 14 | $94,545 | None |
| Established patient complete exam of visual system | 273 | $61,737 | $110 |
| Removal of cataract with insertion of prosthetic lens | 36 | $27,089 | $521 |
| New patient complete exam of visual system | 120 | $14,918 | $124 |
| Imaging of retina | 224 | $14,832 | $36 |
| Injection of drug into eye | 24 | $12,745 | $115 |
| Removal of recurring cataract in lens capsule using a laser | 17 | $7,026 | $319 |
| Photography of the retina | 134 | $5,363 | $34 |
| Exam of visual field with extended testing | 56 | $3,563 | $60 |
| Return visit (30+ min) | 29 | $3,292 | $94 |
| Imaging of optic nerve | 80 | $2,792 | $33 |
| Measurement of corneal curvature and depth of eye | 39 | $2,122 | $39 |
| Exam of the internal drainage system of eye | 48 | $1,413 | $27 |
| Short return visit (20+ min) | 14 | $1,364 | $72 |
| Ultrasound scan of cornea to determine thickness | 50 | $561 | $10 |
Procedures Medicare counted
| Cataract surgery | 54 | More than 65% of doctors who do this |
Who their Medicare patients are
358 Original Medicare patients in 2024. Average age 76 · Women 55% · Also on Medicaid 3% · Health risk score 1.11. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 72% · Diabetes 34% · Coronary heart disease 25% · Chronic kidney disease 18% · Atrial fibrillation 16% · Cancer 15% · Depression 15% · Heart failure 12% · Stroke 9% · COPD 7% · Dementia 5%.
The office billed $783,781, Medicare allowed $385,585 and paid $288,942; for 2,536 services of 30 kinds; $121,393 of it was for drugs given in the office and $167,549 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 358 | 2,536 | 76 | 1.11 | $783,781 | $288,942 |
| 2023 | 265 | 1,853 | 76 | 1.05 | $622,111 | $232,022 |
| 2022 | 314 | 1,971 | 77 | 1.09 | $947,557 | $295,721 |
| 2021 | 334 | 2,123 | 77 | 1.12 | $1,164,219 | $338,101 |
| 2020 | 280 | 2,270 | 76 | 1.21 | $1,276,111 | $374,391 |
| 2019 | 424 | 2,756 | 77 | 1.23 | $1,059,568 | $350,222 |
| 2018 | 454 | 3,429 | 76 | 1.16 | $1,258,233 | $430,388 |
| 2017 | 390 | 2,801 | 77 | 1.09 | $941,557 | $320,214 |
| 2016 | 13 | 25 | 72 | 2.53 | $6,527 | $1,091 |
| 2015 | 19 | 44 | 67 | 1.74 | $15,874 | $3,862 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Injection, aflibercept, 1 mg | 11 | $81,854 | None |
| Established patient complete exam of visual system | 221 | $47,891 | $111 |
| Removal of cataract with insertion of prosthetic lens | 23 | $17,093 | $518 |
| Imaging of retina | 170 | $11,857 | $38 |
| Injection of drug into eye | 23 | $10,178 | $116 |
| New patient complete exam of visual system | 58 | $7,374 | $127 |
| Photography of the retina | 101 | $3,907 | $34 |
| Exam of visual field with extended testing | 41 | $2,546 | $59 |
| Return visit (30+ min) | 13 | $1,957 | $103 |
| Imaging of optic nerve | 56 | $1,939 | $33 |
| Short return visit (20+ min) | 21 | $1,913 | $80 |
| Measurement of corneal curvature and depth of eye | 24 | $1,538 | $39 |
| Exam of the internal drainage system of eye | 40 | $1,162 | $27 |
| Ultrasound scan of cornea to determine thickness | 36 | $380 | $10 |
2022: 15 services
| Injection, aflibercept, 1 mg | 20 | $112,416 | None |
| Established patient complete exam of visual system | 231 | $41,355 | $112 |
| Removal of cataract with insertion of prosthetic lens | 35 | $26,821 | $516 |
| Injection of drug into eye | 38 | $16,169 | $112 |
| Imaging of retina | 212 | $14,818 | $36 |
| Established patient problem focused exam of visual system | 121 | $14,315 | $75 |
| New patient complete exam of visual system | 68 | $7,925 | $117 |
| Removal of recurring cataract in lens capsule using a laser | 15 | $6,855 | $312 |
| Compounded drug, not otherwise classified | 12 | $2,440 | None |
| Photography of the retina | 65 | $2,401 | $35 |
| Exam of visual field with extended testing | 38 | $2,291 | $60 |
| Measurement of corneal curvature and depth of eye | 34 | $2,109 | $36 |
| Imaging of optic nerve | 54 | $1,887 | $33 |
| Exam of the internal drainage system of eye | 37 | $988 | $25 |
| Ultrasound scan of cornea to determine thickness | 35 | $349 | $9 |
2021: 16 services
| Injection, aflibercept, 1 mg | 30 | $147,906 | None |
| Established patient complete exam of visual system | 201 | $28,813 | $111 |
| Established patient problem focused exam of visual system | 182 | $26,949 | $84 |
| Injection of drug into eye | 57 | $19,781 | $112 |
| Removal of cataract with insertion of prosthetic lens | 27 | $18,766 | $521 |
| Imaging of retina | 212 | $14,526 | $39 |
| New patient complete exam of visual system | 58 | $7,619 | $131 |
| Compounded drug, not otherwise classified | 21 | $4,572 | None |
| New patient visit (45+ min) | 37 | $4,341 | $117 |
| Photography of the retina | 115 | $4,129 | $35 |
| Closure of tear duct opening using plug | 12 | $3,207 | $178 |
| Exam of visual field with extended testing | 43 | $2,779 | $62 |
| Measurement of corneal curvature and depth of eye | 32 | $2,423 | $44 |
| Imaging of optic nerve | 39 | $1,383 | $34 |
| Exam of the internal drainage system of eye | 37 | $947 | $26 |
| Ultrasound scan of cornea to determine thickness | 43 | $416 | $9 |
2020: 16 services
| Injection, aflibercept, 1 mg | 29 | $179,710 | None |
| Removal of cataract with insertion of prosthetic lens | 29 | $23,210 | $527 |
| Established patient problem focused exam of visual system | 147 | $23,024 | $84 |
| Injection of drug into eye | 51 | $20,983 | $98 |
| Established patient complete exam of visual system | 127 | $19,676 | $114 |
| New patient visit (45+ min) | 98 | $13,667 | $139 |
| Imaging of retina | 122 | $11,018 | $39 |
| Photography of the retina | 122 | $6,277 | $43 |
| Compounded drug, not otherwise classified | 22 | $4,863 | None |
| Exam of retinal blood vessels using a special camera after injection of a dye | 25 | $2,628 | $105 |
| Measurement of corneal curvature and depth of eye | 36 | $2,285 | $57 |
| Exam of visual field with extended testing | 31 | $2,103 | $66 |
| Imaging of optic nerve | 35 | $1,247 | $35 |
| Exam of the internal drainage system of eye | 33 | $860 | $25 |
| Short return visit | 20 | $706 | $34 |
| Ultrasound scan of cornea to determine thickness | 32 | $332 | $10 |
2019: 19 services
| Injection, aflibercept, 1 mg | 32 | $157,863 | None |
| Removal of cataract with insertion of prosthetic lens | 32 | $32,190 | $619 |
| Established patient problem focused exam of visual system | 208 | $25,143 | $78 |
| Established patient complete exam of visual system | 163 | $20,527 | $115 |
| Photography of the retina | 284 | $18,493 | $48 |
| Imaging of retina | 251 | $17,617 | $39 |
| Injection of drug into eye | 58 | $16,321 | $98 |
| Return visit (30+ min) | 101 | $10,089 | $89 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $4,666 | $333 |
| Exam of visual field with extended testing | 52 | $3,079 | $59 |
| Measurement of corneal curvature and depth of eye | 32 | $2,804 | $62 |
| New patient visit (45+ min) | 18 | $2,646 | $147 |
| New patient complete exam of visual system | 19 | $2,547 | $134 |
| Injection, bevacizumab, 10 mg | 11 | $1,656 | None |
| Imaging of optic nerve | 41 | $1,445 | $34 |
| Exam of the internal drainage system of eye | 51 | $1,388 | $27 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 13 | $1,183 | $91 |
| Short return visit (20+ min) | 20 | $1,150 | $58 |
| Ultrasound scan of cornea to determine thickness | 35 | $389 | $11 |
2018: 19 services
| Injection, aflibercept, 1 mg | 25 | $195,924 | None |
| Return visit (30+ min) | 261 | $38,847 | $93 |
| Removal of cataract with insertion of prosthetic lens | 35 | $35,740 | $606 |
| Photography of the retina | 351 | $33,552 | $56 |
| Imaging of retina | 243 | $20,774 | $39 |
| Established patient problem focused exam of visual system | 152 | $19,580 | $80 |
| Injection of drug into eye | 34 | $15,781 | $96 |
| Established patient complete exam of visual system | 121 | $13,679 | $101 |
| Removal of recurring cataract in lens capsule using a laser | 14 | $5,403 | $318 |
| New patient complete exam of visual system | 36 | $4,567 | $127 |
| New patient visit (45+ min) | 32 | $4,141 | $129 |
| Exam of visual field with extended testing | 55 | $3,443 | $61 |
| Measurement of corneal curvature and depth of eye | 38 | $3,209 | $61 |
| Imaging of optic nerve | 60 | $2,121 | $34 |
| Long return visit (40+ min) | 12 | $1,501 | $125 |
| Exam of the internal drainage system of eye | 55 | $1,427 | $25 |
| Examination of eye by ophthalmoscope with retinal drawing | 23 | $1,362 | $24 |
| Short return visit (20+ min) | 11 | $667 | $61 |
| Ultrasound scan of cornea to determine thickness | 31 | $472 | $13 |
2017: 20 services
| Injection, aflibercept, 1 mg | 11 | $95,075 | None |
| Established patient complete exam of visual system | 266 | $49,646 | $114 |
| Removal of cataract with insertion of prosthetic lens | 43 | $41,198 | $521 |
| Photography of the retina | 248 | $23,180 | $67 |
| Established patient problem focused exam of visual system | 147 | $18,206 | $82 |
| Imaging of retina | 186 | $14,884 | $40 |
| Injection of drug into eye | 24 | $12,648 | $97 |
| Removal of recurring cataract in lens capsule using a laser | 22 | $9,997 | $322 |
| Return visit (30+ min) | 62 | $6,484 | $101 |
| Examination of eye by ophthalmoscope with retinal drawing | 76 | $6,352 | $24 |
| New patient complete exam of visual system | 32 | $4,112 | $129 |
| Examination of eye by ophthalmoscope with retinal drawing | 73 | $3,764 | $26 |
| Imaging of optic nerve | 93 | $3,679 | $35 |
| Injection, bevacizumab, 10 mg | 13 | $3,432 | None |
| Exam of visual field with extended testing | 53 | $3,303 | $62 |
| Measurement of corneal curvature and depth of eye | 42 | $2,726 | $53 |
| Exam of the internal drainage system of eye | 51 | $1,396 | $24 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 11 | $1,374 | $86 |
| New patient problem focused exam of visual system | 11 | $755 | $69 |
| Ultrasound scan of cornea to determine thickness | 12 | $194 | $14 |
Medicaid work
$489 in 2024
Medicaid paid $489 for 25 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 25 | $489 |
| 2024 | 25 | 1 | 12 | $489 |
| 2023 | 24 | 2 | 12 | $0 |
| 2021 | 12 | 1 | 12 | $121 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 12 | $0 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 12 | $0 |
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $121 |
Drugs they prescribed that Part D paid
$90,210
Pharmacies billed $90,210 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,361) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
752 generic and 609 brand-name prescriptions · $90,210 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 42 | $22,057 | $525 |
| Xiidra | 12 | $13,333 | $1,111 |
| Prednisolone Acetate | 177 | $7,315 | $41 |
| Travoprost | 29 | $4,519 | $156 |
| Rhopressa | 11 | $4,462 | $406 |
See all 14 drugs
| Restasis | 42 | $22,057 | $525 |
| Xiidra | 12 | $13,333 | $1,111 |
| Prednisolone Acetate | 177 | $7,315 | $41 |
| Travoprost | 29 | $4,519 | $156 |
| Rhopressa | 11 | $4,462 | $406 |
| Moxifloxacin | 154 | $4,109 | $27 |
| Lotemax Sm | 11 | $2,686 | $244 |
| Latanoprost | 389 | $2,525 | $6 |
| Brimonidine | 35 | $2,398 | $69 |
| Diclofenac | 183 | $1,654 | $9 |
| Timolol Maleate | 143 | $1,247 | $9 |
| Dorzolamide-Timolol | 46 | $473 | $10 |
| Dorzolamide | 18 | $357 | $20 |
| Neomycin-Polymyxin-Dexameth | 16 | $177 | $11 |
Year by year
| 2024 | 1,361 | 252 | 0% (0) | 45% | $90,210 |
| 2023 | 862 | 169 | 0% (0) | 49% | $79,132 |
| 2022 | 920 | 173 | 0% (0) | 51% | $100,573 |
| 2021 | 743 | 170 | 0% (0) | 63% | $95,625 |
| 2020 | 553 | 157 | 0% (0) | 60% | $69,025 |
| 2019 | 521 | 145 | 0% (0) | 58% | $90,617 |
| 2018 | 384 | 109 | 0% (0) | 63% | $80,547 |
| 2017 | 323 | 108 | 0% (0) | 73% | $53,260 |
| 2016 | 144 | 59 | 0% (0) | 65% | $11,387 |
| 2015 | 354 | 98 | 0% (0) | 51% | $20,731 |
| 2014 | 485 | 150 | None | None | $29,235 |
| 2013 | 551 | 153 | 0% (0) | 54% | $31,059 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Restasis | 25 | $17,430 | $697 |
| Prolensa | 45 | $15,806 | $351 |
| Prednisolone Acetate | 107 | $5,851 | $55 |
| Travoprost | 31 | $5,796 | $187 |
| Latanoprost | 264 | $4,553 | $17 |
| Moxifloxacin | 88 | $3,521 | $40 |
| Brimonidine | 22 | $2,108 | $96 |
| Dorzolamide-Timolol | 44 | $1,305 | $30 |
| Timolol Maleate | 88 | $1,265 | $14 |
| Ketorolac Tromethamine | 28 | $844 | $30 |
| Diclofenac | 27 | $283 | $10 |
| Dorzolamide | 13 | $282 | $22 |
| Neomycin-Polymyxin-Dexameth | 11 | $171 | $16 |
| Erythromycin | 12 | $77 | $6 |
2022: 12 drugs
| Restasis | 34 | $24,401 | $718 |
| Prolensa | 43 | $14,894 | $346 |
| Travoprost | 45 | $10,421 | $232 |
| Prednisolone Acetate | 78 | $5,609 | $72 |
| Latanoprost | 341 | $4,922 | $14 |
| Moxifloxacin | 76 | $2,893 | $38 |
| Brimonidine | 15 | $2,701 | $180 |
| Timolol Maleate | 107 | $1,243 | $12 |
| Ketorolac Tromethamine | 30 | $1,102 | $37 |
| Dorzolamide-Timolol | 27 | $620 | $23 |
| Dorzolamide | 21 | $495 | $24 |
| Neomycin-Polymyxin-Dexameth | 15 | $238 | $16 |
2021: 10 drugs
| Restasis | 27 | $18,785 | $696 |
| Prolensa | 42 | $13,052 | $311 |
| Xiidra | 15 | $9,443 | $630 |
| Ilevro | 27 | $8,094 | $300 |
| Travoprost | 36 | $7,237 | $201 |
| Alphagan P | 19 | $6,130 | $323 |
| Prednisolone Acetate | 103 | $5,928 | $58 |
| Moxifloxacin | 83 | $3,189 | $38 |
| Latanoprost | 183 | $2,942 | $16 |
| Timolol Maleate | 98 | $1,030 | $11 |
2020: 11 drugs
| Restasis | 15 | $11,465 | $764 |
| Xiidra | 20 | $11,009 | $550 |
| Prolensa | 30 | $8,484 | $283 |
| Ilevro | 16 | $4,735 | $296 |
| Prednisolone Acetate | 90 | $4,061 | $45 |
| Alphagan P | 14 | $3,446 | $246 |
| Travoprost | 17 | $2,859 | $168 |
| Moxifloxacin | 62 | $2,322 | $37 |
| Latanoprost | 96 | $1,911 | $20 |
| Brimonidine | 11 | $803 | $73 |
| Timolol Maleate | 62 | $702 | $11 |
2019: 13 drugs
| Restasis | 20 | $19,950 | $998 |
| Xiidra | 15 | $7,142 | $476 |
| Azopt | 19 | $6,466 | $340 |
| Travatan Z | 19 | $6,227 | $328 |
| Durezol | 25 | $4,803 | $192 |
| Alphagan P | 11 | $4,382 | $398 |
| Ilevro | 13 | $3,929 | $302 |
| Latanoprost | 114 | $3,371 | $30 |
| Prolensa | 12 | $3,286 | $274 |
| Moxifloxacin | 60 | $2,781 | $46 |
| Brimonidine | 16 | $2,384 | $149 |
| Timolol Maleate | 81 | $1,744 | $22 |
| Prednisolone Acetate | 28 | $1,321 | $47 |
2018: 10 drugs
| Restasis | 14 | $11,528 | $823 |
| Ilevro | 33 | $8,649 | $262 |
| Durezol | 46 | $8,034 | $175 |
| Alphagan P | 16 | $5,303 | $331 |
| Travatan Z | 11 | $5,064 | $460 |
| Lumigan | 13 | $5,018 | $386 |
| Prolensa | 17 | $4,515 | $266 |
| Moxifloxacin | 51 | $2,274 | $45 |
| Latanoprost | 69 | $1,725 | $25 |
| Timolol Maleate | 30 | $312 | $10 |
2017: 9 drugs
| Restasis | 20 | $11,262 | $563 |
| Durezol | 45 | $7,330 | $163 |
| Ilevro | 27 | $6,636 | $246 |
| Vigamox | 40 | $6,277 | $157 |
| Lumigan | 19 | $3,765 | $198 |
| Prolensa | 16 | $3,699 | $231 |
| Latanoprost | 37 | $782 | $21 |
| Prednisolone Acetate | 16 | $735 | $46 |
| Timolol Maleate | 18 | $91 | $5 |
2016: 5 drugs
| Prednisolone Acetate | 24 | $1,052 | $44 |
| Fluorometholone | 16 | $862 | $54 |
| Dorzolamide-Timolol | 12 | $429 | $36 |
| Ketorolac Tromethamine | 12 | $250 | $21 |
| Latanoprost | 12 | $176 | $15 |
2015: 9 drugs
| Lumigan | 20 | $3,281 | $164 |
| Alphagan P | 18 | $2,466 | $137 |
| Prednisolone Acetate | 50 | $2,325 | $46 |
| Brimonidine | 33 | $2,288 | $69 |
| Combigan | 13 | $1,961 | $151 |
| Dorzolamide-Timolol | 32 | $956 | $30 |
| Latanoprost | 88 | $839 | $10 |
| Ketorolac Tromethamine | 32 | $575 | $18 |
| Polymyxin B Sul-Trimethoprim | 32 | $323 | $10 |
2014: 13 drugs
| Restasis | 16 | $4,993 | $312 |
| Travatan Z | 27 | $3,444 | $128 |
| Combigan | 16 | $3,034 | $190 |
| Lumigan | 21 | $2,626 | $125 |
| Brimonidine | 60 | $2,184 | $36 |
| Latanoprost | 121 | $2,035 | $17 |
| Alphagan P | 17 | $1,819 | $107 |
| Dorzolamide-Timolol | 53 | $1,770 | $33 |
| Prednisolone Acetate | 28 | $1,472 | $53 |
| Dorzolamide | 23 | $760 | $33 |
| Ketorolac Tromethamine | 16 | $538 | $34 |
| Polymyxin B Sul-Trimethoprim | 14 | $129 | $9 |
| Timolol Maleate | 12 | $97 | $8 |
2013: 10 drugs
| Brimonidine | 62 | $4,590 | $74 |
| Travatan Z | 44 | $4,493 | $102 |
| Alphagan P | 38 | $4,146 | $109 |
| Combigan | 22 | $2,132 | $97 |
| Dorzolamide-Timolol | 56 | $2,042 | $36 |
| Latanoprost | 118 | $1,927 | $16 |
| Lumigan | 17 | $1,800 | $106 |
| Prednisolone Acetate | 37 | $764 | $21 |
| Dorzolamide | 13 | $560 | $43 |
| Erythromycin | 27 | $409 | $15 |
Money from drug and device companies
$44 in 2025
| 2025 | 1 | 2 | None | $44 |
| 2024 | 3 | 3 | None | $67 |
| 2023 | 2 | 5 | None | $111 |
| 2022 | 11 | 15 | None | $331 |
| 2021 | 3 | 4 | None | $81 |
| 2020 | 5 | 8 | None | $273 |
| 2019 | 11 | 17 | $1,000 | $1,657 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sight Sciences | Omni Surgical System | $44 | 2 payments
|
See all 2 published payments
| Sight Sciences | Meals · 2025-01-30 | Omni Surgical System | $19 |
| Sight Sciences | Meals · 2025-01-29 | Omni Surgical System | $25 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $67
| Glaukos | Idose | $24 | 1 payment
|
| Sight Sciences | Omni Surgical System | $24 | 1 payment
|
| Bausch & Lomb Americas | Miebo | $20 | 1 payment
|
2023: $111
| Alcon Vision | Argos | $85 | 4 payments
|
| Horizon Therapeutics plc | Tepezza | $26 | 1 payment
|
2022: $331
| Genentech USA | Vabysmo | $54 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $45 | 2 payments
|
| Alcon Vision | Argos | $37 | 2 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $37 | 2 payments
|
| EyePoint Pharmaceuticals US | Yutiq | $35 | 1 payment
|
| Eyevance Pharmaceuticals | Flarex | $26 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea | $24 | 1 payment
|
| Allergan | Vuity | $22 | 1 payment
|
| Alimera Sciences | Iluvien | $20 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $19 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $12 | 1 payment
|
2021: $81
| Regeneron Healthcare Solutions | Eylea | $42 | 2 payments
|
| Genentech USA | Lucentis | $25 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $14 | 1 payment
|
2020: $273
| Regeneron Healthcare Solutions | Eylea | $166 | 3 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax | $36 | 2 payments
|
| Genentech USA | Lucentis | $25 | 1 payment
|
| Alimera Sciences | Iluvien | $24 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $23 | 1 payment
|
2019: $1,657
| Alimera Sciences | Iluvien | $1,094 | 2 payments
|
| Novartis Pharmaceuticals | None | $152 | 4 payments
|
| Genentech | Lucentis | $111 | 1 payment
|
| Regeneron Pharmaceuticals | Eylea | $82 | 1 payment
|
| Carl Zeiss Meditec | None | $65 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Lotemax | $53 | 3 payments
|
| Regeneron Healthcare Solutions | Eylea | $24 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $22 | 1 payment
|
| Sun Pharmaceutical Industries | Bromsite | $20 | 1 payment
|
| Allergan | Ozurdex | $18 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Multifocal Family of 1-Piece Iols | $16 | 1 payment
|
Professional record
- NPI
- 1417244831
- Licence
- CA A143148, NC 201501277, PA MT200176, VA 0101259022California A143148: Current · expires 2028-06-30
- Trained
- Jefferson Medical College of Thomas Jefferson University, 2011
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); Student in a training program (390200000X)
- Mailing address
- 2100 Forest Ave Ste 105, San Jose, CA, 95128
- NPI first listed
- 2011-07-06
- NPI last updated
- 2022-03-29
- NPI record certified
- 2022-03-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2110 Forest Ave, San Jose, CA, 95128